tailieunhanh - OUTSIDE DIRECTOR LIABILITY

During a site visit, ACGME Field Staff or Specialist Site Visitors interview the program director, faculty, residents/fellows, clinical department leadership, the designated institutional official (DIO) and other relevant individuals, tailoring questions to the individuals interviewed. The goal is to verify the information in the PIF and to clarify any missing or unclear information by seeking to achieve consensus across all participants and other sources of information. On occasions when a consensus cannot be achieved at the end of the site visit, the Site Visitor reports the different comments and the sources of the information. Site Visitors aggregate their findings into. | Black et al. 58 Stan. L. Rev. 1055 3 9 2006 12 21 03 AM Outside Director Liability Bernard Black Brian Cheffins and Michael Klausner This Article analyzes the degree to which outside directors of public companies are exposed to out-of-pocket liability risk the risk of paying legal expenses or damages pursuant to a judgment or settlement agreement that are not fully paid by the company or another source or covered by directors and officers D O liability insurance. Recent settlements in securities class actions involving WorldCom and Enron in which lead plaintiffs succeeded in extracting out-of-pocket payments from outside directors have led to predictions that such payments will become common. We analyze the out-of-pocket liability risk facing outside directors empirically legally and conceptually and show that this risk is very low far lower than many commentators and board members believe notwithstanding the Worldcom and Enron settlements. Our extensive search for instances in which outside directors of public companies have made out-of-pocket payments turned up thirteen cases in the last twenty-five years. Most involve fact patterns that should not recur today for a company with a state-of-the-art D O insurance policy. We offer a detailed assessment of the liability risk outside directors face in trials under corporate and securities law including settlement dynamics. We Hayden W. Head Regents Chair for Faculty Excellence and Professor of Law University of Texas Law School Professor of Finance McCombs School of Business University of Texas Austin. . Berwin Professor of Corporate Law Cambridge University United Kingdom. Nancy and Charles Munger Professor of Business and Professor of Law Stanford Law School. Appendix A lists the firms included in the survey we conducted in connection with this Article. Many people at those firms were helpful to a degree that went well beyond answering our survey questions and we thank all of them. In addition we thank the .

• Tiếng Anh thương mại
• infectious disease
• Mycobacterium
• disease burden
• highest prevalence
• atypical symptoms
• Mycobacterium tuberculosis
• Field assessment of the efficacy
• LIBDV and Winterfield 2512
• Vaccines against infectious bursal disease
• Infectious bursal disease in chickens
• Immunological efficacy than LIBDV
• Infectious bursal disease
• B lymphocyte
• Review infectious bursal disease
• Major concern in poultry
• Decrease response to vaccination
• Synthetic peptide
• Evaluation of synthetic antigenic peptides
• Diagnosis of infectious bursal disease
• Non vaccinated birds
• BMC Genomics
• Infectious bursal disease virus
• Bursa of Fabricius
• Lethal infectious disease
• JAK STAT signaling pathway
• Immunology
• epidemics
• infectious agents
• the immune system
• biomedicine
• Harrisons infectious disease
• Introduction to infectious diseases
• Fever and approach to the febrile patient
• Infections in organ systems
• Bacterial infections
• risk management
• Harmonised assessment
• epidemic infectious
• intestinal disease
• Disease surveillance
• waterborne outbreaks
• BMC Veterinary Research
• Gumboro disease
• Antigenic regions
• IBD virus
• Pathology of infectious diseases
• Principles of infectious disease pathology
• Herpes virus infections
• Viral hepatitis
• Human papillomavirus
• Respiratory virus infections
• Disease prevalence
• Desi birds
• Retrospective study
• Prevalence of infectious diseases
• Infectious diseases in Desi fowls
• Division of labor
• Functional differentiation
• Ambiguity of genes
• Infectious diseases associated
• Infectious disease expert consult
• The neonatologist
• Ccurrent issues in the pathogenesis
• Treatment of neonatal thrombocytopenia
• Nonhematopoietic effects of erythropoietin
• Coagulation disorders
• Considerations on vaccine mediated prevention
• Breast milk
• Viral infection
• Emerging issues and controversies
• Neonatal fungal infections
• Broiler chickens
• Broiler chickens in Haryana
• Retrospective study on epidemiology
• IBD outbreaks
• BMC Pediatrics
• Associated messaging applications
• Paediatric infectious disease
• Paediatric emergency department
• Including impetigo
• Capture myopathy
• Wild animals
• Important non infectious disease
• Dark red colored urine
• Hind limb affected commonly
• BMC Bioinformatics
• Certain infectious diseases
• Disease prediction
• Highly pathogenic avian influenza
• Infectious disease outbreaks
• Gallus gallus
• RNA sequencing
• De novo
• Immunosuppression in chickens
• Knowledge translation
• Swine infectious disease
• Research synthesis
• Evidence based medicine
• Information sources
• Cardiovascular disease
• Critical care
• Renal disease
• Gastrointestinal disease
• Respiratory disorders
• BMC Public Health
• Double burden of disease
• Social determinants of health
• Noncommunicable disease
• Urban penalty
• Infectious Diseases
• Health Outcomes
• Causal Relationship
• Gulf War
• Respiratory Disease
• Meningococcal Disease
• Viral infections
• prion diseases
• Fungal and algal infections
• Protozoal and helminthic infections
• Laboratory values of clinical importance
• General Epidemics
• Mathematical Approach
• Biomedical Importance
• Host Genetic Factors
• Emerging Diseases
• Insight
• Infectious
• Health
• Sciences
• medicine
• pharmacolocy